Researchers are excited about the medication , a innovative dual agonist showing promising outcomes in early trials for weight reduction . It acts by modulating both hormones : GLP-1 and GIP, which , when https://deannayfoq838609.smblogsites.com/40871887/the-new-possibility-for-size-management